Back to top

Genprex, Roche Partner on NSCLC Biomarker Validation

Genprex ( ($GNPX) ) has issued an update. On August 3, 2026, Genprex announced a collaboration with Roche Diagnostics to validate biomarkers, notab...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

GENPREX (GNPX)